hepatitis b/калијум

Веза се чува у привремену меморију

Изаберите тип сортирања

14 резултати

The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Over one million infants are born to HIV-1-infected women every year in Sub Saharan Africa. In Zimbabwe, annual births stand at 379,000 with approximately 48,000 infants being born every year to HIV-1-infected women on lifelong highly active antiretroviral therapy (HAART). Concerns have been

An Open Study of the Safety and Pharmacokinetics of a Medicinal Product for Emergency Prevention of Ebola

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

The results of the screening of volunteers who signed the informed consent Form, is a sequence set in three groups of volunteers with different doses of the drug, the total number of volunteers who received the drug will be at least 25 people. Taking into account the fact that for the first time the

Twice Against Thrice-weekly Hemodialysis

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Hemodialysis (HD) is the most worldwide prescribed renal replacement therapy for patients with end-stage renal disease. This treatment that relies heavily on technology has undergone major modifications in the last five decades in order to improve patients' outcomes. Those changes that aimed at

Effect of DAAs on Behavior of HCC in HCV Patients

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Introduction: Chronic hepatitis C (HCV) infection can be complicated with liver cirrhosis and subsequently hepatocellular carcinoma (HCC). HCC develops at an annual rate of 1% to 4%, although higher rates up to 7% have been reported in Japan. Recently; Reig et al; noticed that there was an

Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Each subject must sign and date a study-specific informed consent form (ICF) prior to their participation in any screening activities. Prospective subjects should be screened no more than 28 days prior to administration of the first dose of study drug on Day 1. Screening evaluations will be used to

Faecal Microbiota Transplantation in Irritable Bowel Syndrome

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

1. Background Irritable bowel syndrome (IBS) is a chronic, debilitating, functional gastrointestinal disorder with estimated population prevalence in Europe between of 10 -15% (Ford et al). These symptoms can be debilitating and lead to a significant reduction in quality of life particularly in the

Durban Diabetes Study:A Study of the Epidemiology of Diabetes Mellitus in Urban South Africans of African Descent (DDS)

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

STUDY OBJECTIVES - To estimate the prevalence of diabetes mellitus and associated cardiometabolic and infectious risk factors in this population - To provide aetiological insights into the variation in cardiometabolic and infectious risk factors in adults using both population genetic and

Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

This is a safety/efficacy phase II, open, randomized, controlled clinical trial, with two arms. The study population will consist of 30 patients with chronic decompensated liver disease (Child-Pugh B or C). The candidates included in the study will be asked to voluntarily participate and sign the

L-ornithine L-aspartate in Overt Hepatic Encephalopathy

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

A. Introduction and Review of literature Hepatic encephalopathy (HE) is broadly defined as an alteration in mental status and cognitive function occurring in presence of liver failure. The clinical picture of HE arises as a complication of chronic and, more rarely, acute liver disease. HE occurs in

To Study the Efficacy and Safety of Renessans in Chronic HCV Patients

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

1. Primary The primary objective of this study is to assess the efficacy of combination therapy comprising of RENESSANS, INTERFERONS and RIBAVIRIN in the management of treatment naïve HCV related Chronic Active Hepatitis patients. 2. Secondary The secondary objectives of this study are: 1. Determine

Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Objectives: To compare the early versus deferred initiation of antiretroviral combination therapy consisting of tenofovir, emtricitabine and atazanavir/ritonavir in treatment naive patients who present with an acute AIDS-defining illness, namely pneumocystis pneumonia (PCP) or toxoplasma gondii

Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Raltegravir is an HIV-1 integrase inhibitor that is currently licensed for use in treatment-experienced HIV-1 patients and recently approved for use in treatment-naïve patients. Recent data has shown that the virologic response in patients on raltegravir with no history of antiretroviral treatment

Human Upper Extremity (Hand and Forearm) Allotransplantation

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Suitable candidates will be identified via patient information brochures and via advertisements directed at upper limb amputees. For this purpose, a web-page will be constructed for free access by interested individuals. This website will be accessible through standard search engines. Interested

Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis Patients

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Overall study design This is a single-center randomized placebo control study on 60 prevalent PD patients. Recruitment phase will take up to 12 months, and the study phase will be 1 year. Study code will only be revealed at the end of the study period or if patients develop serious adverse

Придружите се нашој
facebook страници

Herbal & Natural Medicine

Најкомплетнија база лековитог биља подржана науком

Ради на 55 језика
Биљни лекови потпомогнути науком
Препознавање биљака по слици
Интерактивна ГПС мапа - означите биље на локацији (ускоро)
Читајте научне публикације повезане са вашом претрагом
Претражите лековито биље по њиховим ефектима
Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима